CD276 and osteosarcoma: Here, we evaluated the effects of Reg-1 KO on the cell-autonomous and non-cell-autonomous functions of CAR T cells targeting B7-H3 (CD276), an antigen expressed on a broad range of pediatric and adult solid tumors27–31, in immune-competent osteosarcoma (OS) models.